Arena Pharmaceuticals, Inc.
6166 Nancy Ridge Drive
San Diego,
CA 92121
United States - Map
Phone: 858-453-7200
Fax: 858-453-7210
Web Site: http://www.arenapharm.com
| Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company also discovers small molecule drug candidates that target G protein-coupled receptors (GPCRs). Its clinical development programs include lorcaserin in Phase 3 trial program for the treatment of obesity; APD791, an anti-thrombotic drug candidate, which has completed Phase 1a and Phase 1b clinical trials; and APD125 that is in Phase 2b clinical trial for the treatment of insomnia. The companys clinical development programs also include APD597, an oral GPR119 agonist that is in Phase 1 clinical trial for the treatment of type 2 diabetes; APD916 drug candidate, which has completed preclinical development for the treatment of narcolepsy and cataplexy; and APD811, a preclinical drug candidate for the treatment of pulmonary arterial hypertension. Its drug candidates use GPCR-focused drug discovery and development approach, as well as technologies, including constitutively activated receptor technology and melanophore technology. The company has collaborations with Merck & Co., Inc. to develop therapeutics for atherosclerosis and related disorders; and Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop compounds for the potential treatment of type 2 diabetes and other disorders. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Jack Lief , 63
Co-Founder, Chairman, Chief Exec. Officer, Pres, Chief Exec. Officer of BRL, Pres of BRL of BRL |
$
968.00K |
$
0 | Dr. Dominic P. Behan Ph.D., 45
Co-Founder, Chief Scientific Officer, Sr. VP |
$
512.00K |
$
0 | Mr. Robert E. Hoffman CPA, 43
Chief Financial Officer, Principal Accounting Officer and VP of Fin. |
$
394.00K |
$
0 | Mr. Steven W. Spector JD, 44
Sr. VP, Sec. and Gen. Counsel |
$
488.00K |
$
0 | Dr. William R. Shanahan Jr., M.D., J.D., 60
Chief Medical Officer and VP |
$
440.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
0.14%
Profile
